WELLEO
LIVE

Serial Number

79447038

Owner

P4Q Health, S.L.

Filing Date

Jan 29, 2026

Add to watchlist:

No watchlists yet
View on USPTO

WELLEO Trademark

Serial Number: 79447038

WELLEO is a trademark filed by P4Q Health, S.L. on January 29, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

P4Q Health, S.L.

Nuestra Señora de la Guía 19

Entity Type: 98

Trademark Details

Filing Date

January 29, 2026

Registration Date

Not Registered

Goods & Services

Dietary supplements; dietetic preparations adapted for medical purposes; vitamin supplements; nutritional supplements; mineral dietary supplements; probiotic supplements; dietetic supplements adapted for medical purposes

Medical diagnostic apparatus for testing for viruses; medical diagnostic testing instruments for use in immunoassay procedures to test for cancer, diabetes, fertility, cardiovascular conditions, hormones, inflammatory conditions, allergies, infectious diseases, metabolism, immune system, bacterial infections, human body minerals, human body vitamins, and human body proteins; immunochemical medical diagnostic testing apparatus for detecting and measuring antibody levels; medical diagnostic apparatus being digital rapid test readers for detecting and quantifying biomarkers and analytes related to cancer, diabetes, fertility, cardiovascular conditions, hormones, inflammatory conditions, allergies, infectious diseases, metabolism, immune system, bacterial infections, human body minerals, human body vitamins, and human body proteins, incorporating software for the monitoring and management of the previously mentioned conditions

Recorded computer software for the detection and quantification of biomarkers and analytes in the fields of cancer, diabetes, fertility, cardiovascular conditions, hormones, inflammatory conditions, allergies, infectious diseases, metabolism, immune system, bacterial infections, human body minerals, human body vitamins, and human body proteins; downloadable computer software for the detection and quantification of biomarkers and analytes in the fields of cancer, diabetes, fertility, cardiovascular conditions, hormones, inflammatory conditions, allergies, infectious diseases, metabolism, immune system, bacterial infections, human body minerals, human body vitamins, and human body proteins; downloadable application software for the detection and quantification of biomarkers and analytes; recorded computer software using artificial intelligence (AI) for the detection and quantification of biomarkers and analytes in the fields of cancer, diabetes, fertility, cardiovascular conditions, hormones, inflammatory conditions, allergies, infectious diseases, metabolism, immune system, bacterial infections, human body minerals, human body vitamins, and human body proteins; downloadable computer software using artificial intelligence (AI) for the detection and quantification of biomarkers and analytes in the fields of cancer, diabetes, fertility, cardiovascular conditions, hormones, inflammatory conditions, allergies, infectious diseases, metabolism, immune system, bacterial infections, human body minerals, human body vitamins, and human body proteins; downloadable application software using artificial intelligence (AI) for the detection and quantification of biomarkers and analytes in the fields of cancer, diabetes, fertility, cardiovascular conditions, hormones, inflammatory conditions, allergies, infectious diseases, metabolism, immune system, bacterial infections, human body minerals, human body vitamins, and human body proteins

Filing History

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 4, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jun 3, 2026 CNRT
ASSIGNED TO EXAMINER
May 27, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 10, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 10, 2026 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 8, 2026 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 2, 2026 REPR